<DOC>
	<DOCNO>NCT00685919</DOCNO>
	<brief_summary>The purpose propose research determine change kidney dopamine ( DA ) activity influence urinary sodium excretion . We decrease DA activity kidney inhibit DA synthesis via carbidopa administration . We want compare finding normal volunteer patient postural tachycardia syndrome ( POTS ) . We test null hypothesis ( Ho ) effect oral carbidopa administration urinary sodium excretion differ patient POTS healthy volunteer .</brief_summary>
	<brief_title>Peripheral Dopamine Postural Tachycardia Syndrome</brief_title>
	<detailed_description>We determine whether inhibition renal dopamine formation carbidopa administration lead decrease urinary excretion dopamine sodium whether response differs POTS control population . Carbidopa effect compare match placebo , sequence treatment ( carbidopa placebo placebo carbidopa ) randomize . Each subject undergo complete history physical examination , include electrocardiogram ( EKG ) . - After achieve sodium balance 200 mEq/day sodium diet , subject collect urine 24hr baseline assessment sodium catecholamine . - On day , subject admit CRC . - An 18 gauge intravenous catheter insert order draw blood . - The subject fast 7 pm next morning 's testing . - In morning , still supine overnight sleep , heart rate blood pressure record , blood drawn . The subject stand 10 minute . Heart rate blood pressure measure interval , upright blood sample collect . - The subject ask collect urine end 24hr urine collection . Another 24hr urine collection start . - Treatment A ( Carbidopa 200mg placebo ) give orally follow void , approximately 7 . Additional dos take every 6 hour last dose 7 follow morning . - Subjects free follow normal routine day return CRC night . However , need consume 200 mEq/day study diet meal , collect urine , take study medication schedule - After return CRC , subject fast 7 pm . - In morning , supine stand heart rate blood pressure record , subject ask collect urine end 24hr urine collection . - The final dose study medication ( Carbidopa 200mg placebo ) give orally follow void , approximately 7 . - Supine heart rate blood pressure measure supine blood sample collect hourly 4 hour treatment 8 hour treatment . Subjects must rest supine least 30 minute blood draw . - At 2 hour treatment , subject stand 10 minute upright blood pressure heart rate measurement collection upright blood sample , describe . Participants ask rate severity common orthostatic symptom supine upright . - Urine collect two 4-hour period treatment 8 hour 24 hour treatment . - Fixed-sodium study diet provide 4-hour measurement even . After least 1 day washout period , study repeat Treatment B</detailed_description>
	<mesh_term>Syndrome</mesh_term>
	<mesh_term>Tachycardia</mesh_term>
	<mesh_term>Postural Orthostatic Tachycardia Syndrome</mesh_term>
	<mesh_term>Orthostatic Intolerance</mesh_term>
	<mesh_term>Dopamine</mesh_term>
	<mesh_term>Dopamine Agents</mesh_term>
	<mesh_term>Carbidopa</mesh_term>
	<criteria>Patients diagnose POTS Vanderbilt Autonomic Dysfunction Center base follow stringent criterion : 1 ) history daily orthostatic symptom least 6 month ; 2 ) increase heart rate ( HR ) least 30 bpm stand stand HR least 120 bpm ; 3 ) absence orthostatic hypotension ( defined fall blood pressure ( BP ) &gt; 20/10 mm Hg ) ; 4 ) absence condition , dehydration , substantial weight loss , systemic illness , could provoke orthostatic intolerance Upright plasma NE least 600 pg/mL patient Nonsmoking Free medication potential influence BP Able willing provide inform consent Overt cause postural tachycardia ( acute dehydration ) Significant cardiovascular , pulmonary , hepatic , hematological disease history screen result Positive urine bhcg pregnancy test Evidence cardiac structural disease ( clinical examination prior echocardiogram ) Hypertension define BP &gt; 145/95 ( medication ) need antihypertensive medication Evidence significant conduction system delay ( QRS duration &gt; 120 m ) electrocardiogram Inability give , withdraw , inform consent</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>60 Years</maximum_age>
	<verification_date>April 2017</verification_date>
	<keyword>Dopamine</keyword>
	<keyword>Natriuresis</keyword>
	<keyword>Catecholamines</keyword>
</DOC>